Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
508.34
-8.00 (-1.55%)
At close: Sep 18, 2026, 4:00 PM EDT
508.50
+0.16 (0.03%)
After-hours: Sep 18, 2026, 7:58 PM EDT

Vertex Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12,58712,00111,0209,8698,9317,574
Revenue Growth
10.23%8.90%11.66%10.51%17.91%22.06%
Gross Profit
6,9186,4415,8595,4445,3234,732
Operating Income
4,9104,6874,3954,3084,3783,892
Net Income
4,4053,953-535.63,6203,3222,342
Earnings Per Share
17.1815.32-2.0813.8912.829.01
EPS Growth
22.12%--8.35%42.29%-12.44%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Trikafta / Kaftrio
10,07810,31310,2398,9457,6875,697
Alyftrek
1,625837.8----
Casgevy
190.5115.810---
Journavx
124.959.6----
Other Collaborative and Royalty
-30.7---1
Other
-644.7771.5924.51,2441,876
Revenue (Total)
12,58712,00111,0209,8698,9317,574

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
13,64212,32011,22413,71610,8917,525
Total Debt
1,9782,0361,750808.4899.7967.4
Net Cash (Debt)
11,66410,2849,47412,9089,9916,558
Net Cash Growth
11.07%8.55%-26.60%29.19%52.36%14.71%
Net Cash Per Share
45.5239.8636.7449.5538.5625.23

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4,2933,631-492.63,5374,1302,644
Capital Expenditures
-496.8-437.6-297.7-200.4-204.7-235
Free Cash Flow
3,7963,194-790.33,3373,9252,409
Free Cash Flow Growth
8.47%---14.99%62.97%-19.55%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.96%53.66%53.17%55.16%59.60%62.48%
Operating Margin
39.01%39.06%39.88%43.65%49.03%51.39%
Pretax Margin
41.90%38.69%2.25%44.38%47.39%36.05%
Profit Margin
35.00%32.94%-4.86%36.68%37.20%30.92%
FCF Margin
30.16%26.61%-7.17%33.81%43.95%31.80%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
29.5929.10-28.9722.3123.84
Forward PE
40.9822.6122.6624.4418.8316.42
P/FCF Ratio
33.9436.02-31.4218.8923.18
PS Ratio
10.249.589.4110.628.307.37